"Hearst Magazines and Yahoo may earn commission or revenue on some items through the links below." Mandy Moore revealed she has a rare blood disorder, immune thrombocytopenic purpura (ITP). The This ...
Rilzabrutinib (Wayrilz; Sanofi), a BTK inhibitor, targets immune-mediated platelet destruction in immune thrombocytopenia (ITP) and has demonstrated a favorable safety profile.
Immune thrombocytopenia (ITP) is a rare blood disorder in which the immune system mistakenly attacks and destroys platelets. Platelets are small blood cells that play a critical role in helping your ...
Living with chronic immune thrombocytopenia (ITP), a blood disorder characterized by low platelet counts, can be stressful.
Early detection and innovative therapies are crucial for managing rare blood disorders like VITT, ITP, and hemophilia. Marstacimab's approval offers a new subcutaneous treatment option for hemophilia ...
Medically reviewed by Gagandeep Brar, MD Key Takeaways ITP does not increase the risk of getting or having severe ...
Tune in to a powerful episode of the AscellaHealth Podcast Pulse, released in recognition of Rare Disease Awareness Month. Hosted by Gabriella Patone of AscellaHealth, this special edition features an ...
More than half of patients in a Phase III clinical trial who received a limited course of the experimental monoclonal antibody ianalumab for primary immune thrombocytopenia (ITP), an autoimmune ...